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Abstract
Human meniscus cells have a predominantly fibrogenic pattern
of gene expression, but like chondrocytes they proliferate in
monolayer culture and lose the expression of type II collagen.
We have investigated the potential of human meniscus cells,
which were expanded with or without fibroblast growth factor 2
(FGF2), to produce matrix in three-dimensional cell aggregate
cultures with a chondrogenic medium at low (5%) and normal
(20%) oxygen tension. The presence of FGF2 during the
expansion of meniscus cells enhanced the re-expression of type
II collagen 200-fold in subsequent three-dimensional cell
aggregate cultures. This was increased further (400-fold) by
culture in 5% oxygen. Cell aggregates of FGF2-expanded
meniscus cells accumulated more proteoglycan (total
glycosaminoglycan) over 14 days and deposited a collagen II-
rich matrix. The gene expression of matrix-associated
proteoglycans (biglycan and fibromodulin) was also increased
by FGF2 and hypoxia. Meniscus cells after expansion in
monolayer can therefore respond to chondrogenic signals, and
this is enhanced by FGF2 during expansion and low oxygen
tension during aggregate cultures.
Introduction
The meniscus is a fibrocartilaginous tissue found within the
knee joint; it is responsible for shock absorption, load distribu-
tion, joint stability and protection of the articular cartilage [1-3].
Unfortunately, the reparative ability of the meniscus is limited,
and injuries to the tissue are often treated by partial or total
menisectomy, which is known to be associated with detrimen-
tal changes in joint function and high incidence of early oste-
oarthritis [4,5]. Cell-based tissue engineering strategies have
been proposed for the generation of meniscus substitute to
aid repair of the tissue [6-10]. Like most musculoskeletal tis-
sues, the biomechanical and functional properties of the
meniscus depend on the composition and organization of its
extracellular matrix (ECM) [1,11]. The cells that produce and
maintain this ECM have been called fibrochondrocytes [12].
Although the predominant morphology of these cells resem-
bles that of the chondrocytes of articular cartilage [1], they
produce predominantly type I collagen with smaller amounts of
types II, III, V and VI collagens, and small amounts of aggrecan
[13]. Isolated primary human meniscus cells show some char-
acteristics similar to those of chondrocytes because during
expansion in monolayer culture there is a sharp decrease in the
expression of collagen type II and a change to predominantly
fibroblast-like morphology [7]. This decline in type II collagen
expression is reminiscent of the loss of differentiated pheno-
type of articular chondrocytes, and the use of these cells for
tissue regeneration of meniscus might lead to the production
of ECM of inferior biomechanical properties. Several investiga-
tors have reported strategies to restore the matrix-forming
phenotype of articular chondrocytes. These include culturing
chondrocytes at high cell densities to prevent cell flattening
[14], in alginate gels [15] to retain the round chondrocytic
morphology, in liquid suspension or in the presence of actin-
disrupting agents, in the presence of fibroblast growth factor
2 (FGF2) [16], retroviral transduction with Sry-related high-
mobility group (HMG) box-9 (SOX9) [17], in three-dimen-
3D = three-dimensional; COL = collagen; DMEM = Dulbecco's modified Eagle's medium; ECM = extracellular matrix; FCS = fetal calf serum; FGF2 
= fibroblast growth factor 2; GAG = glycosaminoglycan; HIF = hypoxia inducible factor; HMG = high-mobility group; L-SOX5 = Sry-related HMG 
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sional (3D) cell aggregate cultures with chondrogenic stimuli
[18] and low oxygen tension (mild hypoxia) [19-21].
In the present study we have investigated the presence of
chondrogenic growth factors and hypoxia with human menis-
cus cells expanded in monolayer culture to determine their
chondrogenic potential. The effect of FGF2 on chondrogenic
potential of meniscus cells was particularly of interest,
because it had been shown to stimulate the growth [22] of
meniscus cells in vitro and also to maintain the ability of mon-
olayer expanded chondrocytes to redifferentiate [16,23].
Materials and methods
Cell isolation and expansion
With informed consent, full-thickness meniscus was har-
vested aseptically from the tibial plateau of patients (aged 48
to 69 years) undergoing total knee replacements. Meniscus
cells were released by incubation for 16 hours at 37°C in
type II collagenase (0.2% w/v) in a standard medium, DMEM
supplemented with 10% FCS, 100 units/ml penicillin and
100 units/ml streptomycin (all from Cambrex, Wokingham,
UK), with l-glutamine (2 mM). Isolated cells were plated at
104 cells/cm2 and cultured in standard medium with or with-
out FGF2 (5 ng/ml) (human recombinant; R&D systems,
Abingdon, UK (added after overnight cell adherence) at
37°C and 20% O2. After about 2 weeks, when cells were
subconfluent, first-passage (P1) cells were detached with
trypsin-EDTA (Invitrogen, Paisley, Renfrewshire, UK) and
split at a 1:2 ratio; culture was continued to produce second-
passage (P2) cells, which were used for experiments. Dou-
bling times of P1 and P2 human meniscus cells were
obtained by plating P1 and P2 meniscus cells at 5 × 105
cells in 75 cm2 tissue culture flasks in the presence and
absence of FGF2 (5 ng/ml). Meniscus cell number was eval-
uated at regular timed intervals in quadruplicate by cell
counting after treatment with trypsin. The doubling time of a
cell population during the exponential growth phase was cal-
culated as the slope of T against ln N/N0), where N0 and N
are the cell number at the beginning and end of the exponen-
tial growth time (T), respectively [16].
Three-dimensional cell aggregate cultures of meniscus cells
were formed by the centrifugation of 5 × 105 cells in 15 ml
conical culture tubes (Corning, Loughborough, UK) at 1,200
r.p.m. for 5 minutes. The cell aggregates were cultured in 0.5
ml of DMEM supplemented with chondrogenic factors, namely
ITS+1, 1.0 mg/ml insulin from bovine pancreas, 0.55 mg/ml
human transferrin (substantially iron-free), 0.5 µg/ml sodium
selenite, 50 mg/ml bovine serum albumin and 470 µg/ml lino-
leic acid 10 nM dexamethasone, 10 ng/ml transforming
growth factor β3, 25 µg/ml ascorbate 2-phosphate (all from
Sigma, Poole, UK) with 10% FCS for 14 days with 5% CO2
under normal oxygen (20% O2) or low oxygen tension (5% O2)
at 37°C. At the end of the culture period, the wet weights of
cell aggregates were recorded. Control monolayer cultures of
meniscus cells with or without FGF2 expansion (R&D sys-
tems) were set up in six-well plates at a 105 cells per well in
standard medium. Monolayer controls were similarly cultured
for 14 days under normoxic and hypoxic culture conditions,
with standard medium change every 2 days.
Gene expression analysis
Total RNA was prepared from whole tissue, monolayer cells
and cell aggregate cultures with the use of Tri-Reagent
(Sigma). Total RNA from tissue was isolated after homogeniza-
tion with a Braun Mikrodismembranator. Cell aggregate cul-
tures were ground up in the Tri-Reagent with Molecular
Grinding Resin (Geno Technology Inc., St Louis, MO, USA). To
minimize any changes in gene expression, cultures caps were
closed before removal from the low-oxygen incubator, and cell
aggregates and monolayers were immediately (less than 1
minute) transferred into Tri-reagent. cDNA was synthesised
from 10 to 100 ng of total RNA with the use of global amplifica-
tion methodology [24]. Globally amplified cDNAs were diluted
1:1000 and 1 µl aliquots of the diluted cDNA were amplified by
polymerase chain reaction in a 25 µl reaction volume in an MJ
Research Opticon 2 real-time thermocycler with a SYBR Green
Core Kit (Eurogentec, Seraing, Belgium), with gene-specific
primers designed by using ABI Primer Express software. Rela-
tive expression levels were normalised with β-actin and calcu-
lated with the use of the 2-∆Ct method [25]. All primers were
from Invitrogen. All primer sequences were designed on the
basis of human sequences as follows: aggrecan, 5'-
AGGGCGAGTGGAATGATGTT-3'  (forward) and 5'-GGT-
GGCTGTGCCCTTTTTAC (reverse); β-actin, 5'-AAGCCAC-
CCCACTTCTCTCTAA-3' (forward) and 5'-
AATGCTATCACCTCCCCTGTGT-3' (reverse); biglycan, 5'-
TTGCCCCCAAACCTGTACTG-3' (forward) and 5'-AAAAC-
CGGTGTCTGGGACTCT-3' (reverse); COL1A2, (collagen)
5'-TTGCCCAAAGTTGTCCTCTTCT-3' (forward) and 5'-
Figure 1
Cell doubling for P1 and P2 meniscus cells in the presence and  absence of FGF2 Cell doubling for P1 and P2 meniscus cells in the presence and 
absence of FGF2. Results are expressed as means ± SD (n = 4). 
FGF2, fibroblast growth factor 2; P1, passage 1; P2, passage 2.Available online http://arthritis-research.com/content/8/3/R61
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AGCTTCTGTGGAACCATGGAA-3' (reverse); COL2A1, 5'-
CTGCAAAATAAAATCTCGGTGTTCT-3' (forward) and 5'-
GGGCATTTGACTCACACCAGT-3' (reverse); COL3A1, 5'-
GGCATGCCACAGGGATTCT-3' (forward) and 5'-
GCAGCCCCATAATTTGGTTTT-3' (reverse); decorin, 5'-
CAAGCTTAATTGTTAATATTCCCTAAACAC-3' (forward) and
5'-ATTTTATGAAGGGAGAAGACATTGGTTTGTTGACA-3'
(reverse); fibromodulin, 5'-TGAAGCACCTTCCCTGAGAAG-
3' (forward) and 5'-GGTTTGGCTTTTGTGGATTCC-3'
(reverse); Sry-related HMG box-5 (long form), L-SOX5 5'-
GAATGTGATGGGACTGCTTATGTAGA-3' (forward) and 5'-
GCATTTATTTGTACAGGCCCTACAA-3' (reverse); Sry-
related HMG box-6 (SOX6), 5'-CACCAGATATCGACA-
GAGTGGTCTT-3' (forward) and 5'-CAGGGTTAAAG-
GCAAAGGGATAA-3' (reverse); SOX9, 5'-
CTTTGGTTTGTGTTCGTGTTTTG-3' (forward) and 5'-AGA-
GAAAGAAAAAGGGAAAGGTAAGTTT-3' (reverse).
Biochemical analysis of cell aggregate cultures
After culture, cell aggregates were digested overnight in 20 µl
of 10 units/ml papain (Sigma), 0.1 M sodium acetate, 2.4 mM
EDTA, 5 mM l-cysteine, pH 5.8, at 60°C. The DNA content of
the papain digest was determined by measuring Hoechst
33258 dye (Sigma) binding with a Hoeffer Dyna Quant 200
fluorometer. Glycosaminoglycans were assayed in the papain
digest by using 1,9-dimethylmethylene blue (Aldrich, Poole,
UK) [26,27] with shark chondroitin sulphate (Sigma) as stand-
ard.
Histology and immunohistochemistry
Cell aggregates were fixed in 4% formaldehyde and embed-
ded in paraffin wax; 5 µm sections were cut and stained with
0.1% safranin-O. For immunohistochemical analysis, sections
were digested with chondroitinase ABC and then incubated
with antibodies against collagen I (sc-8786) or collagen II (sc-
7764) from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Immunolocalised antigens were visualised with a biotin-conju-
gated donkey anti-goat secondary antibody (Santa Cruz Bio-
technology) and a streptavidin-horseradish peroxidase or anti-
rabbit horseradish peroxidase (Sigma) labelling kit with 3,3'-
diaminobenzidine (Dako, Ely, UK). Images were captured with
an Axioplan 2 (Carl Zeiss Ltd, Welwyn Garden City, UK)
microscope and an AxioCam HRc camera (Carl Zeiss), with
AxioVision 4.3 software (Carl Zeiss).
Statistical analysis
Experiments were repeated in triplicate with cells from the
same donor. Gene expression data are presented as the mean
± SD (standard deviation) for the replicates. Statistical signifi-
cance differences between the gene expression values of nor-
moxia and hypoxia cell aggregate cultures were determined
with Student's unpaired t test.
Results
Cell population doubling during monolayer expansion of 
meniscus cells
Cells were isolated from human knee meniscus tissue and cul-
tured in monolayer in the presence and absence of FGF2. The
cells proliferated well in standard medium (without FGF2) and
appeared fibroblastic with a flattened morphology. In the
absence of FGF2, the rate of population cell doubling was
Figure 2
Sox gene expression in monolayer and cell aggregate cultures Sox gene expression in monolayer and cell aggregate cultures. Gene 
expression for monolayer cells (black bars) between P2 and P3 in 
standard medium (n = 3), for cell aggregate (white open bars) culture 
in chondrogenic differentiation medium after 14 days of culture under 
normoxia (n = 3). Gene expression for monolayer cells (light grey bars) 
between P2 and P3 in standard medium (n = 3) and for cell aggregate 
(dark grey bars) in chondrogenic differentiation medium after 14 days 
of culture under low oxygen tension (n = 3). *p < 0.05; **p < 0.001 
(Student's unpaired t test) in cell aggregates from fibroblast growth 
factor 2 (FGF2)-expanded versus non-FGF2-expanded cells. P2, pas-
sage 2; P3, passage 3.Arthritis Research & Therapy    Vol 8 No 3    Adesida et al.
Page 4 of 9
(page number not for citation purposes)
0.14 ± 0.02 per day at P1 and 0.09 ± 0.03 per day at P2.
However, the cells that were expanded in the presence of
FGF2 had an elongated spindle-like cell morphology and pro-
liferated faster, with rates of population doubling 0.22 ± 0.02
per day at P1 and 0.14 ± 0.02 per day at P2 (Figure 1). The
effect of FGF2 expansion on the chondrogenic potential of
meniscus cells was investigated in 3D cell aggregates in the
presence of growth factors known to promote matrix forma-
tion. In addition, the effect of low oxygen tension, which has
previously been shown to enhance matrix assembly by
chondrocytes, was investigated.
Effect of FGF2 expansion on chondrogenic response of 
human meniscus cells
One effect of the expansion with FGF2 on the gene expression
of meniscus cells in monolayer culture was to suppress
COL2A1 and SOX9 expression further than in non-FGF2-
expanded cells. All expanded meniscus cells showed a major
increase in the expression of COL2A1 after 14 days in cell
aggregate cultures. There was a 236-fold increase in
COL2A1 and an 8-fold increase in SOX9 in non-FGF2-
expanded cells, but in FGF2-expanded cells the increase in
COL2A1 was much higher (40,000-fold), as it was for SOX9
(35-fold) (Figures 2 and 3). FGF2 cells therefore showed a
greater potential to regain COL2A1 and SOX9 expression
and final levels of expression exceeded those of non-FGF2-
expanded cells. The expression of COL2A1 and SOX9 was
modulated further by culture at low oxygen tension. In non-
FGF2-expanded cells COL2A1 increased 60-fold and SOX9
12-fold, whereas COL2A1 increased 80,000-fold and SOX9
80-fold in FGF2-expanded cells (Figures 2 and 3). However,
the 80,000-fold increase in COL2A1 expression partly
reflected the initial suppression of COL2A1 expression in
FGF2-expanded monolayer cells. The effect of cell culture with
FGF2 was clearly to generate a cell population that responded
more positively to the cell aggregate culture conditions, and
this response was further enhanced by culture at low oxygen
tension. Surprisingly, the increase in COL2A1 expression was
not accompanied by a significantly higher level of SOX9
expression (p > 0.05). The net effect of FGF2 expansion was
therefore to have no significant (p > 0.05) effect on the expres-
sion of COL1A2 after 14 days cell aggregate culture under
normal oxygen condition, but under hypoxia culture conditions,
the expression of COL1A2 was significantly increased (1.5-
fold; Figure 3). Furthermore, the net effect of FGF2 expansion
in cell aggregate cultures was to significantly increase (p <
0.001) the expression of COL2A1 (200-fold at normal oxygen
tension, and 445-fold under hypoxic culture conditions; Figure
3).
The combination of FGF2 expansion and hypoxia therefore
increased the capacity of meniscus cells to re-express the
matrix-forming phenotype of meniscus cells. Comparison of
these expression levels with cells in tissue showed that
COL1A2 expression in FGF2-derived cell aggregates under
Figure 4
Proteoglycan gene expression in monolayer and aggregate cultures  from non-FGF2 and FGF2 expanded meniscus cells Proteoglycan gene expression in monolayer and aggregate cultures 
from non-FGF2 and FGF2 expanded meniscus cells. Gene expression 
levels for monolayer cells (black bars) between P2 and P3 in standard 
medium (n = 3) and for cell aggregate (white open bars) in chondro-
genic differentiation medium (n = 3) under normal oxygen after 14 days 
in culture. Gene expression for monolayer cells (light grey bars) 
between P2 and P3 in standard medium (n = 3) and for cell aggregate 
(dark grey bars) in chondrogenic differentiation medium (n = 3) under 
hypoxia after 14 days in culture. AGG, aggrecan; BGN, biglycan; DCN, 
decorin; FGF2, fibroblast growth factor 2; FMOD, fibromodulin; P2, 
passage 2; P3, passage 3.Available online http://arthritis-research.com/content/8/3/R61
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low oxygen was 5-fold less than its expression in tissue, while
in non-FGF2-derived cell aggregates under low oxygen
COL1A2 expression was decreased 10-fold relative to its
expression in tissue. In addition, FGF2 expansion increased
the expression of COL2A1 in cell aggregates under low oxy-
gen 5-fold relative to COL2A1 expression in tissue (Figure 3).
However, in view of these changes in COL2A1 expression, it
was surprising that the expression of SOX9 in tissue was 7-
fold that in cell aggregates formed from FGF2-expanded cells
(Figures 2 and 3).
COL3A1, which is not expressed in normal cartilage but is
expressed in meniscus, was expressed similarly in cell aggre-
gates derived from FGF2-expanded and non-FGF2-expanded
cells regardless of oxygen tension, and the expression of
COL3A1 in tissue and in the cell aggregates were at similar
levels (Figure 3).
To characterise the effect of FGF2 expansion on meniscus
cells further, we investigated the gene expression of L-SOX5
and SOX6 and also proteoglycans known to be expressed in
cartilage and meniscus. L-SOX5, SOX6 and SOX9 coopera-
tively activate the expression of COL2A1 [28]. There was no
change in the expression of L-SOX5 and SOX6 in cell aggre-
gates derived from FGF2-expanded meniscus cells (Figure 2).
Aggrecan is the predominant proteoglycan of cartilage and
inner meniscus, and decorin, biglycan and fibromodulin are
small leucine-rich proteoglycans found within the two tissues.
However, the concentration of proteoglycans in meniscal tis-
sue (measured as total glycosaminoglycan (GAG)) is only
12% of the concentration found in cartilage [10,29-31]. Gene
expression analysis of 14-day cell aggregates showed that the
cell aggregates from FGF2 expansion (Figure 4) had signifi-
cantly (p < 0.05) higher expression of biglycan (6-fold) and
fibromodulin (8-fold) (Figure 4). However, at low oxygen ten-
sion only biglycan showed a further increase (3-fold) in expres-
sion. The expression of biglycan was 5-fold higher in cell
aggregates formed from FGF2-expanded cells at low oxygen
tension than in tissue (Figure 4), whereas the expression of
fibromodulin in tissue was 6-fold that in low-oxygen cell aggre-
gates (Figure 4). There were no significant changes in the
mRNA expression of aggrecan but it was one-half that in tissue
(Figure 4). The expression of decorin was low and remained
unchanged between cell aggregates formed from FGF2-
expanded and non-FGF2-expanded cells, but the expression
of decorin was 3-fold to 6-fold lower in cell aggregates than
that in tissue (Figure 4).
Effect of FGF2 expansion on matrix formation and 
proteoglycan matrix deposition
Expanded meniscus cells were cultured in cell aggregates
under conditions known to favour chondrocyte matrix assem-
bly. As a measure of the growth and accumulation of ECM in
the cell aggregate cultures, the wet weights were recorded
after 14 days of culture. The weight of cell aggregates derived
Figure 3
Collagen expression in monolayer and cell aggregate cultures, and in  meniscus tissue with SOX9 expression (n = 3) Collagen expression in monolayer and cell aggregate cultures, and in 
meniscus tissue with SOX9 expression (n = 3). Gene expression levels 
for monolayer cells (light grey bars) between P2 and P3 in standard 
medium (n = 3) and for cell aggregate (dark grey bars) cultures in 
chondrogenic differentiation medium (n = 3) under low oxygen tension 
after 14 days in culture. *p < 0.05; **p < 0.001 (Student's unpaired t 
test) in cell aggregates from fibroblast growth factor 2 (FGF2)-
expanded versus non-FGF2-expanded cells.Arthritis Research & Therapy    Vol 8 No 3    Adesida et al.
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from FGF2-expanded cells was significantly (p < 0.05) higher
(1.5-fold to 2-fold) than that of cell aggregates derived from
cells expanded in the absence of FGF2 regardless of oxygen
tension (Figure 5). Further analysis of GAG production per cell
showed that there was also no significant (p > 0.05) effect of
low-oxygen culture (Figure 5). However, the accumulation of
GAG was 215 to 255% higher in cell aggregate cultures from
FGF2-expanded cells than in those from non-FGF2-expanded
cells.
Histochemical staining of the cell aggregates with safranin-O
was used to assess proteoglycan accumulation. Cell aggre-
gate derived from FGF2-expanded cells under normoxic con-
ditions stained weakly with safranin-O, but the staining was
not uniformly distributed (Figure 6b). In contrast, at low oxygen
tension there was a strongly stained ECM, particularly in the
periphery of the aggregates (Figure 6d). In addition, the cells
in the region of strong safranin-O staining had a more rounded
morphology, reminiscent of chondrocytes in cartilage (Figure
6d), but staining in the central zone of the cell aggregate was
weak. Cell aggregates from non-FGF2-expanded meniscus
cells showed no staining with safranin-O regardless of oxygen
tension (Figure 6a,c).
Effect of FGF2 expansion on collagen deposition
To assess collagen matrix deposition, the cell aggregate cul-
tures were immunostained with antibodies against type II col-
lagen and against type I collagen. The FGF2-expanded cells
(Figure 7b) stained less with anti-collagen type I than cell
aggregates formed from non-FGF2-expanded cells under nor-
mal oxygen tension (Figure 7a,c); under low oxygen tension
both FGF2-expanded cells (Figure 7d) and non-FGF2-
expanded cells (Figure 7c) stained weakly with anti-collagen
type I. Cell aggregates from FGF2-expanded cells (Figure
8b,d) stained strongly for anti-collagen II at 14 days in both
normoxic and low-oxygen cultures. In contrast, little or no anti-
collagen type II staining was observed in cell aggregate from
non-FGF2-expanded cells (Figure 8a,c).
Discussion
Cell-based strategies to engineer a meniscus substitute has
been suggested as an approach to the treatment of meniscal
defects. However, attempts to expand human meniscus cells
in monolayer culture have resulted in decreased gene expres-
sion of ECM components of importance in meniscus function,
such as type II collagen [7], which is located mostly in the inner
region of the tissue and is thought to endow properties suita-
ble for compressive load distribution [13]. In this study we
have investigated the combination of culture under conditions
of low oxygen tension and FGF2-stimulated cell expansion as
a strategy to augment the re-expression of type II collagen and
a matrix-forming phenotype in human meniscus cells. Human
meniscus cells showed a chondrogenic response (increased
collagen II gene and protein expression) when cultured in cell
aggregates regardless of FGF2 presence or absence during
monolayer expansion (Figure 3). However, the response was
much greater in cell aggregate cultures derived from FGF2-
expanded cells (Figure 3). The type II collagen protein was
notably more localized in the matrix at the periphery of the cell
aggregates and more pericellularly at the central region of the
cell aggregates (Figure 8). The chondrogenic response was
further enhanced by low oxygen tension, which caused
increased gene expression of SOX9. However, the expression
of L-SOX5 and SOX6 remained unchanged and low. This was
surprising because L-SOX5 and SOX6 interact cooperatively
with SOX9 to promote the expression of cartilage-specific
genes (such as those encoding COL2A1 and aggrecan) [28].
The enhanced chondrogenic response at low oxygen tension
may involve the transcriptional activity of HIF-1α, (hypoxia
inducible factor) which modulates the expression of a variety
of hypoxia-inducible genes under low oxygen tension [32]. It
has been reported that hypoxia promotes the differentiation of
murine mesenchymal stroma cells along a chondrocyte path-
way in part by activating SOX9 via a HIF-1α-dependent mech-
anism [33]. Furthermore, HIF-1α has been shown to bind to
cAMP-response element-binding protein (CREB)-binding pro-
tein (CBP)/p300 [34], which SOX9 uses to exert its cartilage-
Figure 5
Weights and GAG per DNA content of cell aggregates Weights and GAG per DNA content of cell aggregates. Wet weights of cell aggregate derived from non-FGF2-expanded (black bars) and FGF2-
expanded (grey bars) meniscus cells under normoxia (-) or hypoxia (+), and GAG content of cell aggregate normalised to DNA content. FGF2, 
fibroblast growth factor 2; GAG, glycosaminoglycan.Available online http://arthritis-research.com/content/8/3/R61
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specific type II collagen gene promoter activity [35]. It was
noticeable that in monolayer there was no significant chondro-
genic response in changing from normal oxygen tension
(20%) to low oxygen tension (5%) compared with changing
from monolayer to aggregate (Figure 3). In the comparison
between the expression of cells in aggregates and in monol-
ayer, the 3D structure of a cell aggregate, together with oxy-
gen consumption by the cells, would result in a lower oxygen
tension within the aggregate than in cells in a monolayer. How-
ever, because cell aggregates showed a strong chondrogenic
response at 5% and 20% oxygen, any small difference in oxy-
gen tension was clearly not a major factor driving the chondro-
genic response.
It was notable that the high gene expression of COL1A2 in cell
aggregates formed from FGF2-expanded cells was not corre-
lated with the matrix immunostaining, which was weak with
anti-type I collagen. This suggested that there is a more com-
plex control of type I collagen translation, fibrillogenesis and
matrix deposition.
Further characterization of the chondrogenic response by
human meniscus cells was by gene expression analysis of pro-
teoglycan common to cartilage and meniscus. Aggrecan gene
expression was low in meniscal cells and was not influenced
by FGF2-mediated cell expansion, but its expression
increased in cell aggregate cultures. FGF2-expanded cells
expressed higher levels of biglycan and fibromodulin in cell
aggregates, and this was unaffected by low oxygen. In non-
FGF2-expanded cells, biglycan and fibromodulin expression
was similar in monolayer and cell aggregates, but biglycan was
increased by low oxygen tension in cell aggregates formed
from FGF2-expanded cells. Histology showed an increase in
safranin-O staining in cell aggregates formed from FGF2-
Figure 7
Immunolocalisation of type I collagen in cell aggregates after 14 days of  culture Immunolocalisation of type I collagen in cell aggregates after 14 days of 
culture. Cell aggregates derived from meniscus cells expanded in the 
absence ((a) normoxia; (c) hypoxia) and presence ((b) normoxia; (d) 
hypoxia) of fibroblast growth factor 2 (FGF2). No primary antibody con-
trol and non-specific IgG control. Scale bar, 100 µm.
Figure 6
Safranin-O staining of cell aggregates Safranin-O staining of cell aggregates. Histological analysis and matrix 
accumulation of cell aggregates derived from meniscus cells expanded 
in the absence ((a) normoxia; (c) hypoxia) and presence ((b) normoxia; 
(d) hypoxia) of fibroblast growth factor 2 (FGF2). Scale bar, 100 µm. 
FGF2, fibroblast growth factor 2.Arthritis Research & Therapy    Vol 8 No 3    Adesida et al.
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expanded cells at low oxygen tension. Although this did not
reflect a significant statistical increase in GAG/DNA ratio
under low-oxygen conditions, the cell aggregates formed were
of higher wet weight and this might correspond to a greater
increase in cell number.
This study showed that P2 meniscus cells after growth stimu-
lation with FGF2 were able to re-express type II collagen and
proteoglycans at both the gene and protein levels. Further-
more, this ability was enhanced by 5% oxygen culture condi-
tions and was higher than with meniscus cells expanded in the
absence of FGF2. The cells used in this study were from all
regions of the meniscus and thus include cells from the inner
avascular region, which contains more collagen type II than the
outer vascular region. FGF2 may favour the selective prolifer-
ation of the cells from this region and thus sustain the popula-
tion of meniscus cells with chondrogenic potential. Expansion
with FGF2 has been reported to increase the chondrogenic
potential of human bone marrow stromal cells [36]. Previous
studies by Nakata and colleagues [7] have reported three dis-
tinguishable cell types within the human meniscus tissue:
small round chondrocyte-like cells, elongated fibroblast-like
cells and polygonal cells; they related the loss of collagen II
expression in meniscus cells during monolayer expansion with
the gradual loss of both the chondrocyte-like and polygonal
cell populations to leave predominantly fibroblast-like cells.
The mechanism by which FGF2 conferred this ability to re-
express type II collagen and proteoglycan in meniscus cells is
therefore either by the selective proliferation of chondrogenic
cells within the culture or by maintaining the cells in a more
plastic and responsive state to chondrogenic stimuli [16].
Conclusion
We have shown that the loss of collagen II expression after
monolayer expansion of human meniscus cells can be circum-
vented by adding FGF2 during the monolayer expansion
phase. Furthermore, the ability of FGF2-expanded meniscus
cells to re-express a matrix rich in collagen I and II is enhanced
by hypoxia. This combination strategy may improve cell-based
approaches to generate the biomechanical properties of
meniscus substitutes.
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